Antigenotoxicity studies in Drosophila melanogaster.
The fruit fly Drosophila melangaster with its well developed array of genotoxicity test systems has been used in a number of studies on antigenotoxicity of various compounds and mixtures. In recent years, the newly developed Somatic Mutation and Recombination Tests (SMART) have mainly been employed. These one-generation tests make use of the wing or eye imaginal disc cells in larvae and have proven to be very efficient and sensitive. They are based on the principle that the loss of heterozygosity of suitable recessive markers can lead to the formation of mutant clones of cells that are then expressed as spots on the wings or eyes of the adult flies. We have employed the wing spot test with the two markers multiple wing hairs (mwh,3-0.3) and flare (flr,3-38.8). Three-day-old larvae, trans-heterozygous for these markers, are treated chronically or acutely by oral administration with the test compound(s) or complex mixtures. For antigenotoxicity studies, chronic co-treatments can be used, as well as separate pre-treatments with an antigenotoxic agent followed by a chronic treatment with a genotoxin. After eclosion, the wings of the adult flies are scored for the presence of single and twin spots. These spots can be due to different genotoxic events: either mitotic recombination or mutation (deletion, point mutation, specific types of translocation, etc.). The analysis of two different genotypes (one with structurally normal chromosomes, one with a multiply inverted balancer chromosome) allows for a quantitative determination of the recombinagenic activity of genotoxins. Results of two separate studies presented: (1) instant coffee has antirecombinagenic but not antimutagenic activity in the wing spot test; and (2) ascorbic acid and catechin are able to protect against in vivo nitrosation products of methyl urea in combination with sodium nitrite.
Graf
U
U
Institute of Toxicology, Swiss Federal Institute of Technology (ETH) and University of Zurich, Zurich CH-8603, Schwerzenbach, Switzerland. graf@toxi.biol.ethz.ch
Abraham
S K
SK
Guzmán-Rincón
J
J
Würgler
F E
FE
D000818:Animals; D016587:Antimutagenic Agents / Q000494:pharmacology*; D004331:Drosophila melanogaster / Q000196:embryology / Q000235:genetics*; D005260:Female; D007814:Larva / Q000187:drug effects; D008297:Male; D009152:Mutagenicity Tests; D009154:Mutation; D011995:Recombination, Genetic; D014921:Wings, Animal
D016587:Antimutagenic Agents